NASDAQ:AGIO

Agios Pharmaceuticals Stock News

etoro logo Buy AGIO
*Your capital is at risk
$27.68
+1.17 (+4.41%)
At Close: Jun 03, 2026
Agios Pharmaceuticals receives orphan drug designation for mitapivat from EMA AGIO
Equities research analysts expect Agios Pharmaceuticals Inc (NASDAQ:AGIO) to announce earnings of ($1.70) per share for the current quarter, according to Zacks. Four analysts have provided estimates f
Oppenheimer analyst Mark Breidenbach maintained a Hold rating on Agios Pharma (AGIO – Research Report) today. The company’s shares closed
Agios Pharmaceuticals Inc (NASDAQ:AGIO)’s share price traded down 7.1% during trading on Friday . The stock traded as low as $35.03 and last traded at $35.07, 693,208 shares were traded during tradi
Axa increased its stake in shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO) by 17.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 276,952 shares of the bio
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE